Diacylglycerol kinase α-selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines

Atsumi Yamaki, Rino Akiyama, Chiaki Murakami, Saki Takao, Yuki Murakami, Satoru Mizuno, Daisuke Takahashi, Sayaka Kado, Akinobu Taketomi, Yasuhito Shirai, Kaoru Goto, Fumio Sakane

研究成果: ジャーナルへの寄稿記事

3 引用 (Scopus)

抄録

Diacylglycerol (DG) kinase (DGK), which phosphorylates DG to generate phosphatidic acid (PA), consists of ten isozymes (α–к). Recently, we identified a novel small molecule inhibitor, CU-3, that selectively inhibits the activity of the α isozyme. In addition, we newly obtained Compound A, which selectively and strongly inhibits type I DGKs (α, β, and γ). In the present study, we demonstrated that both CU-3 and Compound A induced apoptosis (caspase 3/7 activity and DNA fragmentation) and viability reduction of AKI melanoma cells. Liquid chromatography-mass spectrometry revealed that the production of 32:0- and 34:0-PA species was commonly attenuated by CU-3 and Compound A, suggesting that lower levels of these PA molecular species are involved in the apoptosis induction and viability reduction of AKI cells. We determined the effects of the DGKα inhibitors on several other cancer cell lines derived from refractory cancers. In addition to melanoma, the DGKα inhibitors enhanced caspase 3/7 activity and reduced the viability of hepatocellular carcinoma, glioblastoma, and pancreatic cancer cells, but not breast adenocarcinoma cells. Interestingly, Western blot analysis indicated that the DGKα expression levels were positively correlated with the sensitivity to the DGK inhibitors. Because both CU-3 and Compound A induced interleukin-2 production by T cells, it is believed that these two compounds can enhance cancer immunity. Taken together, our results suggest that DGKα inhibitors are promising anticancer drugs.

元の言語英語
ページ(範囲)10043-10056
ページ数14
ジャーナルJournal of Cellular Biochemistry
120
発行部数6
DOI
出版物ステータス出版済み - 6 1 2019

Fingerprint

Diacylglycerol Kinase
Melanoma
Phosphotransferases
Phosphatidic Acids
Cells
Apoptosis
Cell Line
Caspase 7
Neoplasms
Caspase 3
Isoenzymes
T-cells
Diglycerides
Liquid chromatography
DNA Fragmentation
Glioblastoma
Pancreatic Neoplasms
Liquid Chromatography
Refractory materials
Interleukin-2

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

これを引用

Diacylglycerol kinase α-selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines. / Yamaki, Atsumi; Akiyama, Rino; Murakami, Chiaki; Takao, Saki; Murakami, Yuki; Mizuno, Satoru; Takahashi, Daisuke; Kado, Sayaka; Taketomi, Akinobu; Shirai, Yasuhito; Goto, Kaoru; Sakane, Fumio.

:: Journal of Cellular Biochemistry, 巻 120, 番号 6, 01.06.2019, p. 10043-10056.

研究成果: ジャーナルへの寄稿記事

Yamaki, A, Akiyama, R, Murakami, C, Takao, S, Murakami, Y, Mizuno, S, Takahashi, D, Kado, S, Taketomi, A, Shirai, Y, Goto, K & Sakane, F 2019, 'Diacylglycerol kinase α-selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines', Journal of Cellular Biochemistry, 巻. 120, 番号 6, pp. 10043-10056. https://doi.org/10.1002/jcb.28288
Yamaki, Atsumi ; Akiyama, Rino ; Murakami, Chiaki ; Takao, Saki ; Murakami, Yuki ; Mizuno, Satoru ; Takahashi, Daisuke ; Kado, Sayaka ; Taketomi, Akinobu ; Shirai, Yasuhito ; Goto, Kaoru ; Sakane, Fumio. / Diacylglycerol kinase α-selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines. :: Journal of Cellular Biochemistry. 2019 ; 巻 120, 番号 6. pp. 10043-10056.
@article{8d8cf53bb48e4aa5bbbf942c2cf45f66,
title = "Diacylglycerol kinase α-selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines",
abstract = "Diacylglycerol (DG) kinase (DGK), which phosphorylates DG to generate phosphatidic acid (PA), consists of ten isozymes (α–к). Recently, we identified a novel small molecule inhibitor, CU-3, that selectively inhibits the activity of the α isozyme. In addition, we newly obtained Compound A, which selectively and strongly inhibits type I DGKs (α, β, and γ). In the present study, we demonstrated that both CU-3 and Compound A induced apoptosis (caspase 3/7 activity and DNA fragmentation) and viability reduction of AKI melanoma cells. Liquid chromatography-mass spectrometry revealed that the production of 32:0- and 34:0-PA species was commonly attenuated by CU-3 and Compound A, suggesting that lower levels of these PA molecular species are involved in the apoptosis induction and viability reduction of AKI cells. We determined the effects of the DGKα inhibitors on several other cancer cell lines derived from refractory cancers. In addition to melanoma, the DGKα inhibitors enhanced caspase 3/7 activity and reduced the viability of hepatocellular carcinoma, glioblastoma, and pancreatic cancer cells, but not breast adenocarcinoma cells. Interestingly, Western blot analysis indicated that the DGKα expression levels were positively correlated with the sensitivity to the DGK inhibitors. Because both CU-3 and Compound A induced interleukin-2 production by T cells, it is believed that these two compounds can enhance cancer immunity. Taken together, our results suggest that DGKα inhibitors are promising anticancer drugs.",
author = "Atsumi Yamaki and Rino Akiyama and Chiaki Murakami and Saki Takao and Yuki Murakami and Satoru Mizuno and Daisuke Takahashi and Sayaka Kado and Akinobu Taketomi and Yasuhito Shirai and Kaoru Goto and Fumio Sakane",
year = "2019",
month = "6",
day = "1",
doi = "10.1002/jcb.28288",
language = "English",
volume = "120",
pages = "10043--10056",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Diacylglycerol kinase α-selective inhibitors induce apoptosis and reduce viability of melanoma and several other cancer cell lines

AU - Yamaki, Atsumi

AU - Akiyama, Rino

AU - Murakami, Chiaki

AU - Takao, Saki

AU - Murakami, Yuki

AU - Mizuno, Satoru

AU - Takahashi, Daisuke

AU - Kado, Sayaka

AU - Taketomi, Akinobu

AU - Shirai, Yasuhito

AU - Goto, Kaoru

AU - Sakane, Fumio

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Diacylglycerol (DG) kinase (DGK), which phosphorylates DG to generate phosphatidic acid (PA), consists of ten isozymes (α–к). Recently, we identified a novel small molecule inhibitor, CU-3, that selectively inhibits the activity of the α isozyme. In addition, we newly obtained Compound A, which selectively and strongly inhibits type I DGKs (α, β, and γ). In the present study, we demonstrated that both CU-3 and Compound A induced apoptosis (caspase 3/7 activity and DNA fragmentation) and viability reduction of AKI melanoma cells. Liquid chromatography-mass spectrometry revealed that the production of 32:0- and 34:0-PA species was commonly attenuated by CU-3 and Compound A, suggesting that lower levels of these PA molecular species are involved in the apoptosis induction and viability reduction of AKI cells. We determined the effects of the DGKα inhibitors on several other cancer cell lines derived from refractory cancers. In addition to melanoma, the DGKα inhibitors enhanced caspase 3/7 activity and reduced the viability of hepatocellular carcinoma, glioblastoma, and pancreatic cancer cells, but not breast adenocarcinoma cells. Interestingly, Western blot analysis indicated that the DGKα expression levels were positively correlated with the sensitivity to the DGK inhibitors. Because both CU-3 and Compound A induced interleukin-2 production by T cells, it is believed that these two compounds can enhance cancer immunity. Taken together, our results suggest that DGKα inhibitors are promising anticancer drugs.

AB - Diacylglycerol (DG) kinase (DGK), which phosphorylates DG to generate phosphatidic acid (PA), consists of ten isozymes (α–к). Recently, we identified a novel small molecule inhibitor, CU-3, that selectively inhibits the activity of the α isozyme. In addition, we newly obtained Compound A, which selectively and strongly inhibits type I DGKs (α, β, and γ). In the present study, we demonstrated that both CU-3 and Compound A induced apoptosis (caspase 3/7 activity and DNA fragmentation) and viability reduction of AKI melanoma cells. Liquid chromatography-mass spectrometry revealed that the production of 32:0- and 34:0-PA species was commonly attenuated by CU-3 and Compound A, suggesting that lower levels of these PA molecular species are involved in the apoptosis induction and viability reduction of AKI cells. We determined the effects of the DGKα inhibitors on several other cancer cell lines derived from refractory cancers. In addition to melanoma, the DGKα inhibitors enhanced caspase 3/7 activity and reduced the viability of hepatocellular carcinoma, glioblastoma, and pancreatic cancer cells, but not breast adenocarcinoma cells. Interestingly, Western blot analysis indicated that the DGKα expression levels were positively correlated with the sensitivity to the DGK inhibitors. Because both CU-3 and Compound A induced interleukin-2 production by T cells, it is believed that these two compounds can enhance cancer immunity. Taken together, our results suggest that DGKα inhibitors are promising anticancer drugs.

UR - http://www.scopus.com/inward/record.url?scp=85058119023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058119023&partnerID=8YFLogxK

U2 - 10.1002/jcb.28288

DO - 10.1002/jcb.28288

M3 - Article

C2 - 30536880

AN - SCOPUS:85058119023

VL - 120

SP - 10043

EP - 10056

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 6

ER -